{"podcast":{"title":"Eyewire News: The Podcast","slug":"eyewire-news-the-podcast-7055536","podcast_index_feed_id":7055536,"rss_url":"https://feeds.megaphone.fm/eyewire","website_url":null,"image_url":"https://megaphone.imgix.net/podcasts/76175cb8-6a11-11ef-a54a-87470a073a58/image/a6563563ccdf4f408d6aad7c3182e268.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"Bryn Mawr Communications (BMC)","episode_count":92,"summary":"Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536"},"episodes":[{"title":"Future of Posterior Therapeutics","slug":"future-of-posterior-therapeutics","published_at":"2026-05-13T18:09:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/future-of-posterior-therapeutics","url":"https://traffic.megaphone.fm/BMCL3508737272.mp3","duration_seconds":658,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/future-of-posterior-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/future-of-posterior-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Bayer Acquires Perfuse in $2.45 Billion Deal","slug":"bayer-acquires-perfuse-in-2-45-billion-deal","published_at":"2026-05-06T18:40:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/bayer-acquires-perfuse-in-2-45-billion-deal","url":"https://traffic.megaphone.fm/BMCL7214816195.mp3","duration_seconds":410,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/bayer-acquires-perfuse-in-2-45-billion-deal/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/bayer-acquires-perfuse-in-2-45-billion-deal.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"How Ophthalmology Strategics are Rewriting the Playbook","slug":"how-ophthalmology-strategics-are-rewriting-the-playbook","published_at":"2026-04-29T19:00:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/how-ophthalmology-strategics-are-rewriting-the-playbook","url":"https://traffic.megaphone.fm/BMCL3181739947.mp3","duration_seconds":370,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/how-ophthalmology-strategics-are-rewriting-the-playbook/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/how-ophthalmology-strategics-are-rewriting-the-playbook.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Glaukos Issued J-Code for Recently Launched Epioxa","slug":"glaukos-issued-j-code-for-recently-launched-epioxa","published_at":"2026-04-22T19:27:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/glaukos-issued-j-code-for-recently-launched-epioxa","url":"https://traffic.megaphone.fm/BMCL9311807982.mp3","duration_seconds":307,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/glaukos-issued-j-code-for-recently-launched-epioxa/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/glaukos-issued-j-code-for-recently-launched-epioxa.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Breaking News from the ASCRS Meeting in Washington DC","slug":"breaking-news-from-the-ascrs-meeting-in-washington-dc","published_at":"2026-04-15T20:39:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/breaking-news-from-the-ascrs-meeting-in-washington-dc","url":"https://traffic.megaphone.fm/BMCL1386597845.mp3","duration_seconds":823,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/breaking-news-from-the-ascrs-meeting-in-washington-dc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/breaking-news-from-the-ascrs-meeting-in-washington-dc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"More than 3 Million Bottles of Eye Drops Recalled","slug":"more-than-3-million-bottles-of-eye-drops-recalled","published_at":"2026-04-08T16:53:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/more-than-3-million-bottles-of-eye-drops-recalled","url":"https://traffic.megaphone.fm/BMCL1147070472.mp3","duration_seconds":281,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/more-than-3-million-bottles-of-eye-drops-recalled/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/more-than-3-million-bottles-of-eye-drops-recalled.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Biogen Enters GA Treatment Market After Major Acquisition","slug":"biogen-enters-ga-treatment-market-after-major-acquisition","published_at":"2026-04-01T19:06:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/biogen-enters-ga-treatment-market-after-major-acquisition","url":"https://traffic.megaphone.fm/BMCL4543424209.mp3","duration_seconds":344,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/biogen-enters-ga-treatment-market-after-major-acquisition/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/biogen-enters-ga-treatment-market-after-major-acquisition.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Interview with ASCRS Executive Director Steve Speares","slug":"interview-with-ascrs-executive-director-steve-speares","published_at":"2026-03-25T20:00:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/interview-with-ascrs-executive-director-steve-speares","url":"https://traffic.megaphone.fm/BMCL8193947080.mp3","duration_seconds":701,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/interview-with-ascrs-executive-director-steve-speares/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/interview-with-ascrs-executive-director-steve-speares.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Alcon and Lensar Call Off Merger","slug":"alcon-and-lensar-call-off-merger","published_at":"2026-03-18T19:31:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger","url":"https://traffic.megaphone.fm/BMCL9514359622.mp3?updated=1773860036","duration_seconds":382,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/alcon-and-lensar-call-off-merger/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"FDA Agrees to Review Phentolamine for Presbyopia","slug":"fda-agrees-to-review-phentolamine-for-presbyopia","published_at":"2026-03-04T21:07:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia","url":"https://traffic.megaphone.fm/BMCL2873046322.mp3","duration_seconds":691,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-agrees-to-review-phentolamine-for-presbyopia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Zeiss Launches App to Improve Workflow","slug":"zeiss-launches-app-to-improve-workflow","published_at":"2026-02-25T20:51:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/zeiss-launches-app-to-improve-workflow","url":"https://traffic.megaphone.fm/BMCL4704664706.mp3","duration_seconds":233,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/zeiss-launches-app-to-improve-workflow/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/zeiss-launches-app-to-improve-workflow.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli","slug":"ocular-releases-phase-3-data-for-wet-amd-candidate-axpaxli","published_at":"2026-02-18T20:08:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/ocular-releases-phase-3-data-for-wet-amd-candidate-axpaxli","url":"https://traffic.megaphone.fm/BMCL5573269039.mp3","duration_seconds":362,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/ocular-releases-phase-3-data-for-wet-amd-candidate-axpaxli/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/ocular-releases-phase-3-data-for-wet-amd-candidate-axpaxli.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Study: Metformin May Lower AMD Progression","slug":"study-metformin-may-lower-amd-progression","published_at":"2026-02-11T20:45:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/study-metformin-may-lower-amd-progression","url":"https://traffic.megaphone.fm/BMCL2441481799.mp3","duration_seconds":306,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/study-metformin-may-lower-amd-progression/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/study-metformin-may-lower-amd-progression.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"First Dual-Agent Eye Drop for Presbyopia Approved","slug":"first-dual-agent-eye-drop-for-presbyopia-approved","published_at":"2026-02-04T20:01:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/first-dual-agent-eye-drop-for-presbyopia-approved","url":"https://traffic.megaphone.fm/BMCL7685905672.mp3","duration_seconds":445,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/first-dual-agent-eye-drop-for-presbyopia-approved/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/first-dual-agent-eye-drop-for-presbyopia-approved.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"FDA Approves Label Supplement for iDose TR","slug":"fda-approves-label-supplement-for-idose-tr","published_at":"2026-01-28T20:00:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-approves-label-supplement-for-idose-tr","url":"https://traffic.megaphone.fm/BMCL6362351584.mp3","duration_seconds":337,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/fda-approves-label-supplement-for-idose-tr/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-approves-label-supplement-for-idose-tr.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Rayner Launches New Phaco System","slug":"rayner-launches-new-phaco-system","published_at":"2026-01-21T21:02:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/rayner-launches-new-phaco-system","url":"https://traffic.megaphone.fm/BMCL7946109655.mp3","duration_seconds":254,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/rayner-launches-new-phaco-system/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/rayner-launches-new-phaco-system.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Moorfields Researchers Reveal Promising Treatment for Hypotony","slug":"moorfields-researchers-reveal-promising-treatment-for-hypotony","published_at":"2026-01-14T20:21:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/moorfields-researchers-reveal-promising-treatment-for-hypotony","url":"https://traffic.megaphone.fm/BMCL5075156056.mp3","duration_seconds":622,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/moorfields-researchers-reveal-promising-treatment-for-hypotony/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/moorfields-researchers-reveal-promising-treatment-for-hypotony.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Staar Terminates Merger with Alcon","slug":"staar-terminates-merger-with-alcon","published_at":"2026-01-07T20:41:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/staar-terminates-merger-with-alcon","url":"https://traffic.megaphone.fm/BMCL5468537677.mp3","duration_seconds":695,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/staar-terminates-merger-with-alcon/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/staar-terminates-merger-with-alcon.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"2025 Year in Review - Part 2","slug":"2025-year-in-review-part-2","published_at":"2025-12-31T05:00:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-2","url":"https://traffic.megaphone.fm/BMCL3297955984.mp3","duration_seconds":525,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/2025-year-in-review-part-2/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-2.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"2025 Year in Review - Part 1","slug":"2025-year-in-review-part-1","published_at":"2025-12-24T05:00:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-1","url":"https://traffic.megaphone.fm/BMCL2456331568.mp3","duration_seconds":577,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/2025-year-in-review-part-1/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-1.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Update on Reproxalap PDUFA Timing","slug":"update-on-reproxalap-pdufa-timing","published_at":"2025-12-17T20:44:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing","url":"https://traffic.megaphone.fm/BMCL3681770584.mp3","duration_seconds":531,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/update-on-reproxalap-pdufa-timing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"New Glaucoma Technologies Advance in Clinical Development","slug":"new-glaucoma-technologies-advance-in-clinical-development","published_at":"2025-12-10T20:32:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/new-glaucoma-technologies-advance-in-clinical-development","url":"https://traffic.megaphone.fm/BMCL4353522812.mp3","duration_seconds":307,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/new-glaucoma-technologies-advance-in-clinical-development/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/new-glaucoma-technologies-advance-in-clinical-development.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Eylea HD Approved for RVO and Extended Dosing","slug":"eylea-hd-approved-for-rvo-and-extended-dosing","published_at":"2025-12-03T20:39:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/eylea-hd-approved-for-rvo-and-extended-dosing","url":"https://traffic.megaphone.fm/BMCL2530398360.mp3","duration_seconds":300,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/eylea-hd-approved-for-rvo-and-extended-dosing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/eylea-hd-approved-for-rvo-and-extended-dosing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Leaders Discuss Emerging Technologies in Glaucoma","slug":"leaders-discuss-emerging-technologies-in-glaucoma","published_at":"2025-11-26T16:30:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/leaders-discuss-emerging-technologies-in-glaucoma","url":"https://traffic.megaphone.fm/BMCL8715817292.mp3","duration_seconds":807,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/leaders-discuss-emerging-technologies-in-glaucoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/leaders-discuss-emerging-technologies-in-glaucoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Live Coverage of B+L Investor Day","slug":"live-coverage-of-b-l-investor-day","published_at":"2025-11-18T21:40:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/live-coverage-of-b-l-investor-day","url":"https://traffic.megaphone.fm/BMCL9472900309.mp3","duration_seconds":419,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/live-coverage-of-b-l-investor-day/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/live-coverage-of-b-l-investor-day.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}